Literature DB >> 8911403

Complications of iliac artery stent deployment.

J L Ballard1, S R Sparks, F C Taylor, J J Bergan, D C Smith, T J Bunt, J D Killeen.   

Abstract

PURPOSE: This study was performed to determine the primary patency, foot salvage, and complication rates associated with iliac artery stent deployment.
METHODS: From March 1992 to May 1995, 147 iliac artery stents were deployed in 98 limbs of 72 patients for disabling claudication or limb-threatening ischemia. Procedure-related and late (> 30 days) complications, as well as adjunctive maneuvers required to correct a complication, were tabulated. Stented iliac artery cumulative primary patency and foot salvage rates were calculated with life-table analysis. Factors that impacted early complications, late complications, foot salvage rates, and stented iliac artery primary patency rates were identified with stepwise logistic regression analysis.
RESULTS: A procedure-related complication occurred in 19 (19.4%) limbs. Initial technical success, however, was achieved in all but three of 98 limbs (96.9%). Stented iliac artery cumulative primary patency rates were 87.6%, 61.9%, 55.3%, and foot salvage rates were 97.7%, 85.1%, 76.1%, at 12, 18, and 24 months, respectively. External iliac artery stent deployment, superficial femoral artery occlusion before treatment, and single-vessel tibial runoff before treatment negatively affected stented iliac artery cumulative primary patency rates. Stented iliac artery primary patency rates were not significantly affected by age, smoking, coronary artery disease, diabetes, hypercholesterolemia, hypertension, presenting symptom, early complication, number of stents deployed, type of stent deployed, or stent deployment for stenosis versus occlusion.
CONCLUSIONS: Limb-threatening and life-threatening complications can be associated with iliac artery stent deployment. Stented iliac artery primary patency rates are affected by distal atherosclerotic occlusive disease and the position of the deployed stent within the iliac system. Stent reconstruction of severe iliac artery occlusive disease is feasible but should be thoughtfully selected.

Entities:  

Mesh:

Year:  1996        PMID: 8911403     DOI: 10.1016/s0741-5214(96)70070-8

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection infusion for chronic lower extremity ischemia: 3-year results.

Authors:  Hai Feng; Xue-ming Chen; Chen-yu Li; Ren-ming Zhu; Jie Fang; Tian-you Wang
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

2.  A newly designed nitinol stent: early clinical experience in the treatment of iliac artery stenoses and occlusions.

Authors:  C J Yoon; J W Chung; J H Park; S H Hong; S Y Song; H G Lim; Y S Lee
Journal:  Korean J Radiol       Date:  2001 Jul-Sep       Impact factor: 3.500

Review 3.  Iatrogenic percutaneous vascular injuries: clinical presentation, imaging, and management.

Authors:  Benjamin H Ge; Alexander Copelan; Dominic Scola; Micah M Watts
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

4.  Toward Data-Driven Learning Healthcare Systems in Interventional Radiology: Implementation to Evaluate Venous Stent Patency.

Authors:  David M Cohn; Tarub S Mabud; Victoria A Arendt; Andre D Souffrant; Gyeong S Jeon; Xiao An; William T Kuo; Daniel Y Sze; Lawrence V Hofmann; Daniel L Rubin
Journal:  J Digit Imaging       Date:  2020-02       Impact factor: 4.056

5.  Mid-term outcomes following endovascular re-intervention for iliac artery in-stent restenosis.

Authors:  Usman Javed; Christopher R Balwanz; Ehrin J Armstrong; Khung-Keong Yeo; Gagan D Singh; Satinder Singh; David Anderson; Gregory G Westin; William C Pevec; John R Laird
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-25       Impact factor: 2.692

6.  The Advantage of Common Femoral Endarterectomy Alone or Combined with Endovascular Treatment.

Authors:  Jun Hyung Kim; Byung Jun So; Seung Jae Byun; Kyung Yun Kim
Journal:  Vasc Specialist Int       Date:  2018-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.